Pregled bibliografske jedinice broj: 519403
BRCA1 and BRCA2 germline mutations in women in Croatia with hereditary predisposition to breast and ovarian cancer
BRCA1 and BRCA2 germline mutations in women in Croatia with hereditary predisposition to breast and ovarian cancer // Final Program and Abstracts of The 7th ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine / Schanfield, Moses ; Primorac, Dragan ; Vuk-Pavlović, Stanimir (ur.).
Zagreb: International Society for Applied Biological Sciences (ISABS), 2011. str. 256-256 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 519403 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
BRCA1 and BRCA2 germline mutations in women in Croatia with hereditary predisposition to breast and ovarian cancer
Autori
Levačić Cvok, Mirela ; Musani, Vesna ; Sušac, Ilona ; Ozretić, Petar ; Sabol, Maja ; Car, Diana ; Eljuga, Domagoj ; Eljuga, Ljerka ; Levanat, Sonja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Final Program and Abstracts of The 7th ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine
/ Schanfield, Moses ; Primorac, Dragan ; Vuk-Pavlović, Stanimir - Zagreb : International Society for Applied Biological Sciences (ISABS), 2011, 256-256
Skup
FIFTH CROATIAN CONGRESS ON HUMAN GENETICS
Mjesto i datum
Bol, Hrvatska, 20.06.2011. - 21.06.2011
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
hereditary breast cancer; BRCA1 gene; BRCA2 gene; population genetics; genetic epidemiology
Sažetak
Epidemiological data indicates 5-15% of all breast cancer cases are hereditary, and germline mutations in Breast Cancer Gene 1 (BRCA1) and Breast Cancer Gene 2 (BRCA2) account for the majority of hereditary breast and ovarian cancers. The contribution of BRCA1 and BRCA2 mutations to hereditary breast and ovarian cancer in Croatia is unknown. The aim of our study was to estimate the incidence and spectrum of pathogenic mutations in BRCA1 and BRCA2 genes in high risk women in Croatia. The screening was performed by high resolution melting approach, direct sequencing and semi-quantitative multiplex PCR method (Cvok et al. Clin Chem Lab Med 2008 ; 46(10):1376-83). Protocols were certified by EMQN (European Molecular Genetics Quality Network). The complete coding sequences and exon-intron boundaries analyses of both genes were carried out on 142 women with hereditary predisposition to breast and ovarian cancer. Overall, 11 pathogenic mutations were detected, two novel in BRCA1, and three novel in BRCA2. Nineteen BRCA1 and 33 BRCA2 unclassified variants and polymorphisms were also identified, of which two BRCA1 and seven BRCA2 were not previously published. This is the first molecular investigation of the hereditary predisposition to breast and ovarian cancer in Croatia based on BRCA1 and BRCA2 genes. Samples were collected from different regions of the country and the level of pathogenic mutations and distribution of polymorphic variants will contribute to population statistics. This study was funded by The Terry Fox Run 2009 donation and supported by The Terry Fox Foundation and Croatian League Against Cancer.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2461 - Prijenos signala u tumorima: Hh-Gli put, interakcije i potencijalne terapije (Levanat, Sonja, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Vesna Musani
(autor)
Petar Ozretić
(autor)
Ljerka Eljuga
(autor)
Diana Trnski
(autor)
Maja Sabol
(autor)
Sonja Levanat
(autor)